This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer | MicrobiomeTrials
← Back to trials NCT06077500
DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-02-14Est. Completion: 2026-09-01
Enrollment target: 46 participantsLocations Orlando Health Cancer Institute, Orlando, Florida, United States Emory University, Atlanta, Georgia, United States Cliniques Universitaires Saint-Luc, Brussels, Belgium AZ Groeninge, Kortrijk, Belgium INS Bergonie, Bordeaux, France Hôpital Louis Pradel, Bron, France HOP Civil, Strasbourg, France Institut Gustave Roussy, Villejuif, France Universitätsklinikum Gießen und Marburg GmbH, Giessen, Germany Saitama Medical University International Medical Center, Saitama, Hidaka, Japan Hamamatsu University Hospital, Shizuoka, Hamamatsu, Japan National Cancer Center Hospital, Tokyo, Chuo-ku, Japan Japanese Foundation for Cancer Research, Tokyo, Koto-ku, Japan Medical University Gdansk, Gdansk, Poland Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland MED POLONIA SP Z O O, Clinical Trials Department,Poznan, Poznan, Poland Hospital Universitario Ramon Y Cajal, Madrid, Spain Fundación Jiménez Díaz, Madrid, Spain Other microbiome trials you might be interested in Metastatic Non-Squamous Non-Small Cell Lung Cancer Adult Solid Tumor
This is an exploratory, signal-finding, randomized, placebo-controlled, blinded, multi-center phase 2b trial of the anti…
Birmingham, United States Est. completion Oct 1, 2029
SCLC Extensive-stage Small Cell Lung Cancer
The purpose of this Medical Access Program (also referred to as an Expanded Access Program in the USA) is to provide acc…
Salina, United States
Hospital Universitario Virgen De La Macarena, Seville, Spain
Instituto Valenciano de Oncología, Valencia, Spain
University Hospital of Lausanne, Lausanne, Switzerland Recruiting
Prospective, biological, observational study involving the collection and use of samples from patients suffering from NS…
Rome, Italy Est. completion Jul 24, 2026